The largest community for pharma industry writers and readers

JOIN 2020 TPMG ONLINE PHARMA SUMMIT

CALL FOR AUTHOR - 2020 FEATURED WRITERS

TPMG FEATURED WRITER NEWSLETTER

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is...

Top 10 Most Important Advisor Questions

Today, I would like to share the top 10 most important advisor questions that every brand team should keep in mind...

Optimizing Survivorship Care in Oncology

I have previously discussed a range of topics related to the diagnosis and treatment of cancer, including the use...

“Go-to-Market”: Medical Affairs, Strategies and Timings

“Go-to-Market” in Pharma is defined as a tactical action plan, that outlines the needed steps to succeed in a...

Field Medical Affairs In Pharma/Biotech: Effectiveness, Opportunities and Challenges

  Medical Affairs has risen very fast in the last years, becoming after an initial phase of “supporting function”, a...

Navigating Emerging Markets – Opportunities and Challenges for Pharma

The pharmaceutical industry is quickly evolving; to stay relevant and competitive, companies need to stay on top of the...

The Zeigarnik Effect – What is it and how can it help increase productivity?

As I discussed in my recent webinar on the power of habit, habits, whether conscious or subconscious, are the...

Medical Insights in Pharma Industry by Tommaso Salanitri

Gain an insight means obtain an accurate and deep understanding about some (complex) situation. Medical insights represent one of the most...

Patient Experience is not Customer Experience and Pharma needs to get this.

The search volume of the term "Patient Experience" increased almost 550% in the past decade. Consultants, agencies, start ups...

Business Analysis in Pharma Industry: from Market Research to Patient Journey. A Medical Affairs view

by Tommaso Salanitri, MD Business analysis in Pharma industry, either during the early phases of drug development phase or close...

Preparing for take-off: a ticket to first class MCM planning

by Jan Keuppens “Omnichannel strategist / head of Marketing” @ Across health You wouldn’t attempt to fly a plane without first...

Targeting the Tumor Microenvironment

Investigators are always looking for new and innovative ways to treat cancer. This is a constantly and rapidly evolving...

Why Pharma Needs to Care About Global Warming

A version of this article was previously published on Pharmaphorum. Barely a day goes by without global warming or climate...

Business Plan: a Medical Affairs perspective

A business plan is generally considered a process and specifically, a document, that summarizes the operational and financial objectives...

Rare Diseases at Roche: Combining science and alliances to find breakthroughs in rare diseases

One of the biggest events in the rare disease calendar – the Huntington Disease Society of America annual convention – is...

EDITOR´S PICK

Sermo Reports Hydroxychloroquine Usage Expands Globally, Plasma Is Perceived as More Effective Than Hydroxychloroquine, Remdesivir Efficacy Perceptions on the Rise

NEW YORK--(BUSINESS WIRE)--Week two data of the Barometer study from 5,000 physicians in 30 countries conducted by Sermo reveals...

Novavax to start human trial for novel coronavirus vaccine

(Reuters) - Novavax Inc said on Wednesday it had identified a novel coronavirus vaccine candidate and would start human...

MedinCell Has Launched a COVID-19 Research Initiative Based on Its Experience to Formulate Long-Acting Injectable Ivermectin

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: MedinCell (Paris:MEDCL) Researchers at Monash University in Melbourne, Australia, have published last Friday a study showing that...

Gilead Completes Acquisition of Forty Seven, Inc.

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction for Toro...

Masks do reduce spread of flu and some coronaviruses, study finds

LONDON (Reuters) - Face masks could help limit the spread of the COVID-19 pandemic, according to researchers who studied...

Pfizer Receives European Approval for Oncology Biosimilar, RUXIENCE™ (rituximab)

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that the European Commission (EC) has approved RUXIENCE™ (rituximab), a monoclonal...

Exclusive: Sanofi can produce millions of doses of potential coronavirus drug – CEO

PARIS (Reuters) - Sanofi SA will be able to provide millions of doses of hydroxychloroquine for patients with the...

Axial Biotherapeutics Announces Positive Topline Results from Phase 1b/2a Clinical Trial of AB-2004 for the Treatment of Autism Spectrum Disorder

WALTHAM, Mass.--(BUSINESS WIRE)--Axial Biotherapeutics, a biotechnology company dedicated to building a unique class of gut-targeted programs for neurodegenerative diseases...

Fauci says threats to his personal security ‘secondary’ to curbing coronavirus

WASHINGTON (Reuters) - The infectious diseases expert at the forefront of the U.S. fight against the coronavirus outbreak on...

EU will avoid medicine shortage, industry chief says

PARIS (Reuters) - European Union countries will have access to the medicines they need to care for coronavirus sufferers,...

Why is New Orleans’ coronavirus death rate seven times New York’s? Obesity is a factor

(Reuters) - The coronavirus has been a far deadlier threat in New Orleans than the rest of the United...

Trump accuses hospitals of hoarding ventilators

WASHINGTON (Reuters) - U.S. President Donald Trump accused hospitals on Sunday of hoarding ventilators that are in scarce supply...

FDA Accepts Genentech’s New Drug Application for Xofluza for the Treatment of Influenza in Children

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced that...

U.S. health agency lists hydroxychloroquine under hoarding prevention after Trump’s order

(Reuters) - The Health and Human Services on Thursday listed malaria drug hydroxychloroquine as a medical resource that was...

AHF Demands Gilead Drop Exclusive ‘Orphan Drug’ Claim on COVID-19 Treatment

WASHINGTON--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) today is calling on Gilead Sciences Inc., one of the largest manufacturers of HIV/AIDS...

LOOK WHO IS ON THE MOVE!

Coeus Consulting Group Continues its Expansion with the Hiring of Two Key Executives

DEVON, Pa.--(BUSINESS WIRE)--Coeus Consulting Group, a leading boutique life science consulting firm, today announced it has hired two executives...

Professor Dame Carol Black, Internationally-Renowned Physician on Connective Tissue Disorders, Joins Riptide Bioscience Advisory Board

VALLEJO, Calif.--(BUSINESS WIRE)--Riptide Bioscience, Inc., today announced that Dame Carol M. Black, FRCP, MACP, FMedSci, Foreign Associate Member of...

ReAlta Life Sciences Strengthens Board of Directors with Election of Edward Heidt as Chair and Appointments of Dr. Jonathan Zalevsky and Christine Neikirk

NORFOLK, Va.--(BUSINESS WIRE)--ReAlta Life Sciences, Inc., a biotech company dedicated to harnessing the power of the immune system through...

Acceleron Announces Retirement of Director Jean George

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (Nasdaq:XLRN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of TGF-beta superfamily...

OSSIO Appoints Healthcare Industry Veteran Gary J. Pruden to Board of Directors

WOBURN, Mass.--(BUSINESS WIRE)--OSSIO, Inc., an orthopedic fixation company dedicated to improving orthopedic outcomes and experiences, today announced the appointment...

Polyneuron Appoints Seasoned Pharmaceutical Executive Debra Barker as Chief Medical Officer

BASEL, Switzerland--(BUSINESS WIRE)--Polyneuron Pharmaceuticals AG, a developer of a new class of biodegradable glycopolymers for the treatment of autoimmune...

Michael Greco, JD Joins Rallybio to Head Legal Operations

NEW HAVEN, Conn.--(BUSINESS WIRE)--Rallybio LLC, a biopharmaceutical company committed to identifying and accelerating the development of life-transforming therapies for...

Vor Biopharma Appoints Dr. Robert Pietrusko as Chief Regulatory and Quality Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, today...

GlycoMimetics Appoints Dr. Myra Rosario Herrle as Vice President, Regulatory Affairs

ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that veteran regulatory expert Myra Rosario Herrle, PhD, RPh, RAC, has...

Veracyte Names Tracy Morris as Vice President of Corporate Communications and Investor Relations

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Veracyte, Inc. (Nasdaq: VCYT) today announced that it has named Tracy Morris as vice president...

Bigfinite Announces Senior Leadership Additions

SAN FRANCISCO--(BUSINESS WIRE)--Bigfinite, Inc. (Bigfinite), the leading manufacturing data analytics platform company for regulated industries, today announced that John...

PolarityTE Announces the Addition of Audit Executive Chris Nolet to Board of Directors

SALT LAKE CITY--(BUSINESS WIRE)--PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today...

AlloVir Appoints Ugo Capolino Perlingieri Head of Europe and Middle East Operations

CAMBRIDGE, Mass.--(BUSINESS WIRE)--AlloVir, a late-clinical stage T-cell immunotherapy company, today announced that Ugo Capolino Perlingieri has been appointed to...

Seres Therapeutics Appoints Lisa von Moltke, M.D., as Chief Medical Officer

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seres Therapeutics, Inc., (Nasdaq: MCRB) today announced the appointment of Lisa von Moltke, M.D., FCP, as Executive...

Stimwave Technologies Names Aure Bruneau Chief Executive Officer

POMPANO BEACH, Fla.--(BUSINESS WIRE)--Stimwave Technologies, Inc., a global medical device company that provides minimally invasive, MRI-compatible battery-free implantable devices...

REGULATORY AFFAIRS

Scholar Rock Announces Issuance of U.S. Patent Broadly Relevant to Antibodies that Modulate TGFβ Activation

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which...

ReForm Biologics Announces the Issuance of U.S. and Japanese Patents for Therapeutic Protein Formulations

WOBURN, Mass.--(BUSINESS WIRE)--ReForm Biologics, a pharmaceutical technology company developing innovative biologic formulations to improve drug delivery and manufacturing, expanded...

U.S. FDA Approves BRAFTOVI® (Encorafenib) in Combination with Cetuximab for the Treatment of BRAFV600E-Mutant Metastatic Colorectal Cancer (CRC) After Prior Therapy

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI®...

FDA Grants Breakthrough Device Designation to DNAe’s Sequencing Diagnostic

LONDON & CARLSBAD, Calif.--(BUSINESS WIRE)--DNAe, the next generation sequencing company developing novel diagnostics for use at the point-of-need, today...

FDA Grants Vapotherm® Oxygen Assist Module (OAM™) Breakthrough Device Designation

EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO) (“Vapotherm” or the “Company”), a global medical technology company focused on the development...

Genentech Provides Regulatory Update on Risdiplam for the Treatment of Spinal Muscular Atrophy (SMA)

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that...

Bristol Myers Squibb Announces Acceptance of U.S. and EU Regulatory Filings for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Combined with Limited Chemotherapy in First-Line Lung...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb (NYSE:BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted its...

Acceleron Receives FDA Breakthrough Therapy Designation for Sotatercept in Pulmonary Arterial Hypertension

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (Nasdaq: XLRN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of TGF-beta...

Blaze Bioscience Announces FDA Has Granted Fast Track Designation to BLZ-100 (tozuleristide) for Pediatric Central Nervous System Tumors

SEATTLE--(BUSINESS WIRE)--Blaze Bioscience, Inc., the Tumor Paint Company®, a biotechnology company dedicated to improving the lives of cancer patients...

Alnylam Completes Rolling Submission of New Drug Application to the U.S. Food and Drug Administration and Submits Marketing Authorization Application to the European Medicines...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced the completion of the rolling...

Merck Receives Priority Review from FDA for Second Application for KEYTRUDA® (pembrolizumab) Based on Biomarker, Regardless of Tumor Type

KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S....

Know Labs Granted Patent for its Bio-RFID™ Technology

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced that it has been...

New first-in-class cholesterol-lowering treatment NILEMDO® and its combination with ezetimibe NUSTENDI® approved in Europe

MUNICH--(BUSINESS WIRE)--Daiichi Sankyo Europe GmbH (hereafter, ‘Daiichi Sankyo’) today announced that the European Commission (EC) has approved both NILEMDO®...

LFB Announces FDA Approval of SEVENFACT®, a New Recombinant Coagulation Factor VIIa, for the Treatment of Adults and Adolescents with Hemophilia A or B...

LES ULIS, France--(BUSINESS WIRE)--LFB today announced that the US Food and Drug Administration (FDA) has approved the Biologics License...

Hope Biosciences Receives FDA Approval to Commence First Stem Cell Clinical Trial for Protection Against COVID-19

HOUSTON--(BUSINESS WIRE)--Hope Biosciences, a clinical stage biotechnology company focused on developing cell-based therapeutics for acute and chronic disease, today...

RESEARCH AND DEVELOPMENT

NeoImmuneTech Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate NT-I7 (Hyleukin-7™) in Combination with Nivolumab

ROCKVILLE, Md.--(BUSINESS WIRE)--NeoImmuneTech, Inc., a clinical-stage T cell-focused biopharmaceutical company, today announced it has entered into a clinical collaboration...

Tenax Therapeutics Announces Last Patient Completes Final Visit in its Phase 2 “HELP Study” of Levosimendan for Pulmonary Hypertension and Heart Failure with Preserved...

MORRISVILLE, N.C.--(BUSINESS WIRE)--Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on identifying, developing and commercializing products that...

NeuClone Announces Completion of Subject Visits in Stelara® (ustekinumab) Biosimilar Phase I Clinical Trial

SYDNEY--(BUSINESS WIRE)--NeuClone Pharmaceuticals Ltd (NeuClone), a clinical-stage biopharmaceutical company exclusively focused on developing high-quality biosimilar products, today announced successful...

AIVITA Biomedical Provides Update of Ongoing Phase 2 Glioblastoma Trial from Year-End Survival Analysis

IRVINE, Calif.--(BUSINESS WIRE)--AIVITA Biomedical, Inc., a biotechnology company specializing in innovative cell therapy applications, announced today updated survival data...

BELLUS Health Announces Completion of Dosing in Phase 2 RELIEF Trial with BLU-5937 for the Treatment of Refractory Chronic Cough

LAVAL, Quebec--(BUSINESS WIRE)--BELLUS Health Inc. (Nasdaq: BLU; TSX: BLU) (the “Company” or “BELLUS Health”) , a clinical-stage biopharmaceutical company...

Can-Fite Reports Positive Top Line Results from its Phase II NASH Study with Namodenoson

PETACH TIKVA, Israel--(BUSINESS WIRE)--Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE:CFBI), a biotechnology company advancing a pipeline of proprietary small...

Millendo Therapeutics Announces Topline Results for Pivotal Phase 2b Study of Livoletide in Patients with Prader-Willi Syndrome (PWS)

ANN ARBOR, Mich.--(BUSINESS WIRE)--Millendo Therapeutics, Inc. (Nasdaq: MLND), a biopharmaceutical company primarily focused on developing novel treatments for endocrine...

The Lancet Simultaneously Publishes Two Phase 3 Studies Detailing Comprehensive Efficacy and Safety of TREMFYA®▼ (guselkumab), a First-in-Class IL-23 p19 Subunit Inhibitor, in Psoriatic...

BEERSE, Belgium--(BUSINESS WIRE)--The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that The Lancet has published comprehensive data...

Incyte Announces First Presentation of Phase 3 Data from the TRuE-AD Program of Ruxolitinib Cream at the Revolutionizing Atopic Dermatitis Virtual Symposium

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq: INCY) today announced the first presentation of Phase 3 data for ruxolitinib cream in atopic...

Jichi Medical University and CureApp, Inc.: The First Phase 3 Clinical Trials of "Digital Therapeutics" for Hypertension Begin in Japan

TOKYO--(BUSINESS WIRE)--CureApp, Inc. (Head Office, Chuo-ku, Tokyo; President and CEO, Kohta Satake, M.D.), developer of software as a medical...

UroGen Announces Positive Interim Data from Phase 2b Study of UGN-102 in Patients with Low-Grade Intermediate Risk Non-Muscle Invasive Bladder Cancer

PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq:URGN) announced positive interim data analysis of UGN-102 (mitomycin) for intravesical solution in patients...

Zymeworks Announces First Patient Dosed in Phase 1b/2 Trial of ZW25 in First-Line HER2-Positive Breast Cancer and Gastroesophageal Adenocarcinoma Conducted by BeiGene

VANCOUVER--(BUSINESS WIRE)--Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that its partner, BeiGene, Ltd.,...

As Part of a Global Partnership with Nestlé Health Science, VALBIOTIS Initiates the Pivotal Late Stage Development Phase of TOTUM-63, a Plant-Derived Active Substance...

LA ROCHELLE, France--(BUSINESS WIRE)--Regulatory News: VALBIOTIS (Paris:ALVAL) (FR0013254851 – ALVAL / PEA/SME eligible), a Research & Development company committed to...

NOXXON Announces Completion of Patient Recruitment for the First Dose Cohort in the Phase 1/2 Brain Cancer Study Of NOX-A12 Plus Radiotherapy

BERLIN--(BUSINESS WIRE)--Regulatory News: NOXXON Pharma N.V. (Paris:ALNOX) (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments...

FINANCIAL NEWS

Avivagen Announces Results From Its Annual General Meeting April 8, 2020

Business Wire We Apologize for the Inconvenience. Our Team is Working to Resolve the Issue. If You Have Questions or...

QIAGEN Announces Preliminary Q1 2020 Results

VENLO, The Netherlands--(BUSINESS WIRE)--QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced preliminary sales and adjusted earnings per...

Lantheus Holdings, Inc. Reports Preliminary Q1 Revenue Near Top End of Previously Disclosed Guidance Range; Withdraws 2020 Financial Guidance

NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Holdings, Inc. (NASDAQ: LNTH) (“Lantheus” or the “Company”), parent company of Lantheus Medical Imaging, Inc....

CONMED Corporation to Announce First Quarter 2020 Financial Results on April 29, 2020

UTICA, N.Y.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the first quarter of...

BiomX Announces Date of 2020 Annual Meeting of Stockholders

NESS ZIONA, Israel--(BUSINESS WIRE)--BiomX Inc. (the “Company”) (NYSE: PHGE), a clinical-stage company developing both natural and engineered phage therapies...

Pfizer to Hold Virtual-Only 2020 Annual Meeting of Shareholders

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that its 2020 Annual Meeting of Shareholders will be held in...

Verastem Oncology Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM) (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and commercializing medicines to...

SilverCloud Health Announces $16M Series B Funding for Digital Mental Health Platform

BOSTON--(BUSINESS WIRE)--SilverCloud Health, the world's leading digital mental health platform for healthcare systems and providers, health plans, and employers,...

Important Update For CEL-SCI Corporation Annual Meeting of Shareholders

VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM), announced today that there are now two options to access the virtual...

Axonics® to Report First Quarter 2020 Financial Results on May 5

IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel...

GlycoMimetics Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

ROCKVILLE, Md.--(BUSINESS WIRE)--GlycoMimetics, Inc. (the “Company”) (NASDAQ:GLYC) today announced that the compensation committee of the Company’s Board of Directors...

KalVista Pharmaceuticals Provides Operational and Financial Update

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery, development,...

Hologic to Announce Financial Results for the Second Quarter of Fiscal 2020 on Wednesday, April 29, 2020

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the...

Elanco Confirms Date and Conference Call for First Quarter 2020 Financial Results Announcement

GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will announce its first quarter 2020 financial results on Thursday, May...

Insulet to Announce First Quarter 2020 Financial Results on May 7, 2020

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with...

INDUSTRY NEWS

LambdaVision Wins NASA Award to Further Advance Development of an Artificial Retina to Help Patients Regain Sight

FARMINGTON, Conn.--(BUSINESS WIRE)--LambdaVision, an innovative biotech developing a novel treatment to help patients regain sight, along with implementation partner,...

Open-Source Healthcare App Released Globally for Free

LONDON--(BUSINESS WIRE)--Traction on Demand and Thrive Health announced free, global availability for a new open-source mobile application for healthcare...

 ICON wins multiple categories in 2020 CRO Leadership Awards third year in a row

DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a global provider of drug development and commercialisation services to the pharmaceutical, biotechnology and...

LabCorp and Ciox Health Enter Collaboration to Create Comprehensive Patient Data Registry

BURLINGTON, N.C. & ALPHARETTA, Ga.--(BUSINESS WIRE)--LabCorp (NYSE: LH), a leading global life sciences company that is deeply integrated in...

Vizient Announces Agreement with One Network Enterprises to Bring Increased Resiliency, Transparency and Collaboration to the Health Care Supply Chain

IRVING & DALLAS, Texas--(BUSINESS WIRE)--Vizient, Inc. and One Network Enterprises today announced an agreement to bring increased resiliency, transparency...

Scientist.com and HealthEconomics.Com Partner to Enable Online Sourcing of Health Economics and Outcomes Research (HEOR) and Real World Evidence (RWE)

SAN DIEGO--(BUSINESS WIRE)--Scientist.com, the pharma industry’s leading marketplace for outsourced research, has partnered with HealthEconomics.Com, the world’s leading Connected...

i2O Therapeutics Raises $4 million in Seed Funding Co-led by Sanofi Ventures and JDRF T1D Fund

BOSTON--(BUSINESS WIRE)--i2O Therapeutics, an innovative biotech company developing a platform for oral delivery of traditionally injectable biological drugs, announced...

TFF Pharmaceuticals Announces R&D Collaboration with the University of Georgia for a Universal Influenza Vaccine

AUSTIN, Texas--(BUSINESS WIRE)--TFF Pharmaceuticals, Inc. (NASDAQ: TFFP), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products...

Horizon Therapeutics plc Named One of the 2020 Best Workplaces in Health Care and Biopharma by Fortune and Great Place to Work®

DUBLIN--(BUSINESS WIRE)--Horizon Therapeutics plc (NASDAQ:HZNP) today announced it has been selected as one of the 2020 Best Workplaces in...

F-star Therapeutics Announces Data on Potent Anti-Tumor Activity of FS120 Published in Cancer Immunology Research

CAMBRIDGE, England & CAMBRIDGE, Mass.--(BUSINESS WIRE)--F-star Therapeutics Ltd., a clinical-stage biopharmaceutical company focused on transforming the lives of patients...

Sangamo Announces Closing of Biogen Collaboration Agreement

BRISBANE, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced the closing of its previously announced...

NeoImmuneTech Announces Clinical Collaboration with Bristol Myers Squibb to Evaluate NT-I7 (Hyleukin-7™) in Combination with Nivolumab

ROCKVILLE, Md.--(BUSINESS WIRE)--NeoImmuneTech, Inc., a clinical-stage T cell-focused biopharmaceutical company, today announced it has entered into a clinical collaboration...

Tango Therapeutics Raises $60 Million Series B Financing and Strengthens Executive Team

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tango Therapeutics, a biotechnology company focused on discovering and delivering the next generation of targeted cancer therapies,...

Bio-Rad Acquires Celsee, Inc., a Single-Cell Analysis Solutions Provider

HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic...

NIH Awards Grant to NDRI for Continued Autism Research Support

PHILADELPHIA--(BUSINESS WIRE)--The National Disease Research Interchange (NDRI) has been awarded a research grant of $275,000 to continue to support...

EVENTS NEWS

Quanterix Corporation to Participate in the 19th Annual Needham Virtual Healthcare Conference

BILLERICA, Mass.--(BUSINESS WIRE)--Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis to advance the science of precision health, today...

X4 Pharmaceuticals to Present and Participate in the Virtual 19th Annual Needham Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel therapies targeting diseases...

Exelixis to Webcast Virtual Fireside Chat as Part of the Needham Healthcare Conference on April 15, 2020

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced that members of Exelixis’ management team will participate in a fireside...

Tricida to Present at the Needham Virtual Healthcare Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the 19th Annual Needham...

KalVista Pharmaceuticals to Present at 19th Annual Needham Healthcare Conference

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery,...

JTC Team and LaVoieHealthScience to Host Virtual Investor Summit on April 22 and 23, 2020

BOSTON & NEW YORK & PITTSTOWN, N.J.--(BUSINESS WIRE)--JTC Team (“JTC”) and LaVoieHealthScience (“LHS”), today announced their partnership to host...

Revance to Participate in the 19th Annual Needham Virtual Healthcare Conference

NEWARK, Calif.--(BUSINESS WIRE)--Revance Therapeutics, Inc. (Nasdaq: RVNC), a biotechnology company focused on innovative aesthetic and therapeutic offerings, including its...

Moderna to Present at 19th Annual Needham Healthcare Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to...

Aimmune Therapeutics to Present at the 19th Annual Needham Virtual Healthcare Conference

BRISBANE, Calif.--(BUSINESS WIRE)--Aimmune Therapeutics, Inc. (Nasdaq: AIMT), a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies,...

Seattle Genetics to Webcast Virtual Fireside Chat at Needham Healthcare Conference

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (Nasdaq:SGEN) announced today that management will participate in a fireside chat at the Needham...

Aerie Pharmaceuticals to Present at the Needham Virtual Healthcare Conference

DURHAM, N.C.--(BUSINESS WIRE)--Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class...

Moderna to Host Virtual Vaccines Day on April 14, 2020

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc., (Nasdaq: MRNA) a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to...

Bicycle Therapeutics to Participate in a Panel Discussion at the Canaccord Genuity Horizons in Oncology Conference

CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of...

Invacare Corporation to Participate in the 19th Annual Needham Healthcare Conference

ELYRIA, Ohio--(BUSINESS WIRE)--Matt Monaghan, chairman, president and chief executive officer of Invacare Corporation (NYSE:IVC), will participate in a fireside...

Castle Biosciences to Present at the 19th Annual Needham Virtual Healthcare Conference

FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer...

COVID-19

SpotSee Donates Temperature Indicators to Mexico for COVID-19 Specimens

DALLAS--(BUSINESS WIRE)--SpotSee®, a global leader in supply chain temperature indicators used to monitor test specimens in the SARS and...

Gilead Announces $20 Million Philanthropic Fund to Support Nonprofit Organizations Impacted by the COVID-19 Crisis

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced the creation of the global Gilead CARES (COVID-19 Acute Relief...

Information is Power: First Databank Arms Healthcare Professionals and Consumers with COVID-19 Resources They Can Trust

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--First Databank, Inc. (FDB), the leading provider of drug and medical device knowledge that helps...

Data on arthritis drug to treat coronavirus could come within weeks: Regeneron executive

(Reuters) - Initial data from clinical trials testing whether patients with severe coronavirus illness can be helped by a...

U.S. CDC reports 427,460 coronavirus cases, 14,696 deaths

FILE PHOTO: Drone pictures show bodies being buried on New York's Hart Island where the department of corrections...

France more than doubles crisis package cost to 100 billion euros

PARIS (Reuters) - The French government on Thursday more than doubled the expected cost of its coronavirus crisis measures...

New York sees drop in new hospitalizations, deaths keep rising

(Reuters) - New York state saw a sharp drop in the number of people newly admitted to a hospital...

As fever checks become the norm in coronavirus era, demand for thermal cameras soars

(Reuters) - The makers of specialized cameras to quickly scan for fevers as people enter crowded workplaces are grappling...

Turkey’s coronavirus death toll reaches 908 with 42,282 total cases: minister

FILE PHOTO: A worker in a protective suit sprays disinfectant at Grand Bazaar, known as the Covered Bazaar,...

U.S. urged to go slow on easing coronavirus lockdown, even as jobless claims surge

WASHINGTON/NEW YORK (Reuters) - The top U.S. infectious disease expert on Thursday warned against reopening the economy too soon...

Indonesian barber gears up to groom during coronavirus

BOGOR, Indonesia (Reuters) - Indonesian hair stylist Herman Maulanasyah knows that he may look comical in his makeshift protective...

NIH begins trial to test hydroxychloroquine for treating COVID-19

FILE PHOTO: Researches at the University of Minnesota Genomics Center set up an automated liquid handler as researchers...

Dubai to set up field hospitals to cope with any coronavirus surge: official

DUBAI (Reuters) - The emirate of Dubai is preparing field hospitals to handle any surge in cases of the...

In Uganda, mothers in labour die amidst coronavirus lockdown

KAMPALA (Reuters) - Scovia Nakawooya’s unborn child died inside her as she struggled to reach a hospital on foot....

U.S. coronavirus deaths top 15,000: Reuters tally

FILE PHOTO: Healthcare workers prepare to transfer the body of a deceased person at Kingsbrook Jewish Medical Center...

NATALIE YEADON

“Fake News” and Credibility in Medical Publishing

A version of this article was previously published on Pharmaphorum. Doubtlessly, one of the defining phrases of the 2010s is...

Top 10 Most Important Advisor Questions

Today, I would like to share the top 10 most important advisor questions that every brand team should keep in mind...

Optimizing Survivorship Care in Oncology

I have previously discussed a range of topics related to the diagnosis and treatment of cancer, including the use...

Navigating Emerging Markets – Opportunities and Challenges for Pharma

The pharmaceutical industry is quickly evolving; to stay relevant and competitive, companies need to stay on top of the...

The Zeigarnik Effect – What is it and how can it help increase productivity?

As I discussed in my recent webinar on the power of habit, habits, whether conscious or subconscious, are the...

Targeting the Tumor Microenvironment

Investigators are always looking for new and innovative ways to treat cancer. This is a constantly and rapidly evolving...

Why Pharma Needs to Care About Global Warming

A version of this article was previously published on Pharmaphorum. Barely a day goes by without global warming or climate...

Medical Marijuana and Cannabinoids for Cancer Therapy

Medical marijuana – or cannabis – is one of the hottest topics in oncology right now. This is especially...

Biologics and Biosimilars in Oncology

With many patents about to expire in coming years, the field of biologics in oncology is about to change...

Real-world Evidence (RWE) for Regulatory and Reimbursement Decisions

We have previously discussed the potential roles of real-world data (RWD) and real-world evidence (RWE) for drug access. However,...

Barriers to Personalized Medicine in Oncology

Did you know that the top 10 highest grossing drugs in the United States only help between 4-25% of...

Bionics and Exoskeleton Components for Patient Assistance

What is Bionics and Why Should You Care? Bionics – also known as biomechatronics – is the study of mechanical...

Artificial Intelligence in Pharma

Artificial intelligence, or AI for short, is one of the most highly anticipated digital healthcare technologies. While the concept of...

Future Thinking for Pharmaceutical Market Research

We have recently discussed several important considerations for pharma when looking into the future. While some future directions seem...

Behavioral Science in Pharma

To stay relevant, pharma and healthcare companies need to move beyond the pill. Instead, the focus needs to shift...